Tadalafil
CAS No. 171596-29-5
Tadalafil ( IC351, IC-351, IC 351, Tadalafil, Adcirca, Cialis )
Catalog No. M12614 CAS No. 171596-29-5
Tadalafil is a potent phosphodiesterase-5 (PDE5) inhibitor (IC50=1 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 45 | In Stock |
|
50MG | 66 | In Stock |
|
100MG | 101 | In Stock |
|
200MG | 169 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTadalafil
-
NoteResearch use only, not for human use.
-
Brief DescriptionTadalafil is a potent phosphodiesterase-5 (PDE5) inhibitor (IC50=1 nM).
-
DescriptionTadalafil is a potent phosphodiesterase-5 (PDE5) inhibitor (IC50=1 nM); no inhibition on most of the other families of PDEs, with the exception of PDE11.Sexual Dysfunction Approved
-
SynonymsIC351, IC-351, IC 351, Tadalafil, Adcirca, Cialis
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE5
-
Research AreaEndocrinology
-
IndicationSexual Dysfunction
Chemical Information
-
CAS Number171596-29-5
-
Formula Weight389.40
-
Molecular FormulaC22H19N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 52 mg/mL
-
SMILESO=C([C@@]1([H])CC2=C([C@@H](C3=CC(OCO4)=C4C=C3)N15)NC6=C2C=CC=C6)N(C)CC5=O
-
Chemical NamePyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Blount MA, et al. Mol Pharmacol, 2004, 66(1), 144-152.
2. Ring BJ, et al. Clin Pharmacol Ther, 2005, 77(1), 63-75.
2. Ring BJ, et al. Clin Pharmacol Ther, 2005, 77(1), 63-75.
molnova catalog
related products
-
PF 05180999
PF-05180999 (PF 5180999) is a potent, selective, brain-penetrating and orally bioavailable phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 1 nM.
-
Gisadenafil
Gisadenafil is a selective inhibitor of phosphodiesterase 5 (PDE5) with an IC50 of 3.6 nM and prevents degradation of cGMP.
-
MBCQ
MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins.